Pharmaceutical major Lupin on Friday announced that it has received approval from the United States Food and Drug Administration (USFDA) to market Modafinil tablets which are used to treat excessive sleepiness.
According to the company’s statement, it received approval from the US drug regulator for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP in 100 mg and 200 mg strengths.